EDITORIAL
Scaling up antiretroviral therapy in developing countries: what are the benefits and challenges?
1 University of Cape Town, South Africa
2 Médicins San Frontières, South Africa
Correspondence to:
A Boulle, University of Cape Town, PO Box 13203 Mowbray, South Africa; andrew.boulle@uct.ac.za
Accepted 2 October 2007
| The first 150 words of the full text of this article appear below. |
In recent years the case for antiretroviral therapy (ART) in those countries hardest hit by the HIV pandemic is seldom contested. Prior to the widespread availability of antiretroviral therapy in many developing countries, there were however frequent concerns expressed about the safety and feasibility of promoting widespread access to ART in countries such as those in Southern Africa. These concerns were premised on the potential "anarchy" that might be the result of weak health systems leading to widespread virological resistance,1 2 on the grounds that there were more cost-effective interventions available given the limited funding baskets at the time,3 and on the potential to do more harm than good if introducing large and complex new interventions into already weak and fragmented health systems, further increasing inequities.4 5
The first public-sector ART treatment programmes in developing countries (with the exception of Brazil) date back to 2000,6 and data are now emerging on the
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
- Full Text
- Full Text (PDF)
- Submit a response
- Alert me when this article is cited
- Alert me when eLetters are posted
- Alert me if a correction is posted
- Citation Map
Services
- Email this link to a friend
- Similar articles in this journal
- Similar articles in PubMed
- Add article to my folders
- Download to citation manager
- Request Permissions
Citing Articles
Google Scholar
PubMed
Topic Collections
-
Epidemiology
-
Immunology (including allergy)
-
Drugs: infectious diseases
-
HIV/AIDS
- Sexual transmitted infections (viral)
Bookmark with
Register for free content
The full back archive is now available for all BMJ Journals. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006 right back to volume 1 issue 1. Register here to access the free archive of all BMJ Journals.
Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.
